QuidelOrtho (QDEL) Cash & Equivalents (2021 - 2026)

QuidelOrtho (QDEL) has 6 years of Cash & Equivalents data on file, last reported at $140.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 10.46% year-over-year to $140.4 million; the trailing twelve-month figure through Mar 2026 stood at $140.4 million (up 10.46% YoY), and the FY2025 full-year result was $169.8 million, up 72.74% from the prior year.
• Cash & Equivalents retreated to $140.4 million in Q1 2026, from $169.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q2 2022 to a low of $79.0 million in Q1 2024.
• A 5-year average of $271.4 million and a median of $150.8 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 77.74% in 2024 and jumped 72.74% in 2025, its largest moves.
• Tracing QDEL's Cash & Equivalents over 5 years: stood at $213.2 million in 2022, then sank by 43.95% to $119.5 million in 2023, then declined by 17.74% to $98.3 million in 2024, then jumped by 72.74% to $169.8 million in 2025, then slipped by 17.31% to $140.4 million in 2026.
• Business Quant data shows QDEL's Cash & Equivalents at $140.4 million in Q1 2026, $169.8 million in Q4 2025, and $98.1 million in Q3 2025.